文献速递中枢神经肿瘤放疗放疗物理与技术

基于深度学习的低场脑磁共振引导放疗合成CT生成

Deep Learning-Based Synthetic Computed Tomography for Low-Field Brain Magnetic Resonance-Guided Radiation Therapy.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2024-10-01

研究前瞻性纳入12例胶质瘤患者,在0.35T磁共振直线加速器上构建条件生成对抗网络,从低场磁共振图像生成合成CT用于剂量计算。模型生成的合成CT在视野内平均绝对误差为70.9±10.4 HU,靶区D95平均剂量差异为-0.07±0.29 Gy,3%/3mm gamma通过率为99.9%±0.1%。

要点

  • 条件生成对抗网络可从0.35T低场磁共振图像生成高质量脑合成CT,靶区D95平均剂量差异为-0.07±0.29 Gy。
  • 危及器官剂量差异在[-0.14, 0.02] Gy内,仅右晶状体D0.01cc存在显著差异但总体差异<0.13 Gy。
  • 9例患者在不同磁共振直线加速器上二次验证,合成CT性能无显著差异且剂量学结果可比。

核心结论

  • 条件生成对抗网络模型从低场磁共振图像生成高保真脑合成CT,剂量学性能优异。
  • 二次验证提示合成CT有望用于在线自适应脑磁共振引导放疗的稳健剂量计算。

研究设计与样本

  • 前瞻性纳入12例胶质瘤患者的模拟磁共振-CT配对图像,使用头颈表面线圈在0.35T磁共振直线加速器上采集,用于训练模型。
  • 模型由9个残差块的生成器和PatchGAN判别器组成,采用四折交叉验证。
  • 二次验证使用9例患者,在不同磁共振直线加速器上采用高分辨率脑线圈进行。

主要发现

  • 视野内合成CT的平均绝对误差为70.9±10.4 HU,峰值信噪比为28.4±1.5 dB,结构相似性指数为0.87±0.02。
  • 术后异常表现代表性不足对模型性能构成挑战。
  • 真实CT与合成CT的剂量体积直方图指标平均差异:靶区D95为-0.07±0.29 Gy,危及器官在[-0.14, 0.02] Gy内。
  • 仅右晶状体D0.01cc观察到显著差异,总体差异<0.13 Gy。
  • 1%/1 mm、2%/2 mm、3%/3 mm的gamma分析平均通过率分别为92.2%±3.0%、99.2%±0.7%、99.9%±0.1%。

关键数值与推荐

  • 合成CT质量评估指标:平均绝对误差70.9±10.4 HU、峰值信噪比28.4±1.5 dB、结构相似性指数0.87±0.02。
  • 靶区D95平均剂量差异为-0.07±0.29 Gy,危及器官剂量差异在[-0.14, 0.02] Gy内。
  • gamma分析通过率:1%/1 mm为92.2%±3.0%,2%/2 mm为99.2%±0.7%,3%/3 mm为99.9%±0.1%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 术后异常表现代表性不足对模型性能构成挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Magnetic resonance (MR)-guided radiation therapy enables online adaptation to address intra- and interfractional changes. To address the need of high-fidelity synthetic computed tomography (synCT) required for dose calculation, we developed a conditional generative adversarial network for synCT generation from low-field MR imaging in the brain. METHODS AND MATERIALS: Simulation MR-CT pairs from 12 patients with glioma imaged with a head and neck surface coil and treated on a 0.35T MR-linac were prospectively included to train the model consisting of a 9-block residual network generator and a PatchGAN discriminator. Four-fold cross-validation was implemented. SynCT was quantitatively evaluated against real CT using mean absolute error (MAE), peak signal-to-noise ratio (PSNR), and structural similarity index measure (SSIM). Dose was calculated on synCT applying original treatment plan. Dosimetric performance was evaluated by dose-volume histogram metric comparison and local 3-dimensional gamma analysis. To demonstrate utilization in treatment adaptation, longitudinal synCTs were generated for qualitative evaluation, and 1 offline adaptation case underwent 2 comparative plan evaluations. Secondary validation was conducted with 9 patients on a different MR-linac using a high-resolution brain coil. RESULTS: Our model generated high-quality synCTs with MAE, PSNR, and SSIM of 70.9 ± 10.4 HU, 28.4 ± 1.5 dB, and 0.87 ± 0.02 within the field of view, respectively. Underrepresented postsurgical anomalies challenged model performance. Nevertheless, excellent dosimetric agreement was observed with the mean difference between real and synCT dose-volume histogram metrics of -0.07 ± 0.29 Gy for target D95 and within [-0.14, 0.02] Gy for organs at risk. Significant differences were only observed in the right lens D0.01cc with negligible overall difference (<0.13 Gy). Mean gamma analysis pass rates were 92.2% ± 3.0%, 99.2% ± 0.7%, and 99.9% ± 0.1% at 1%/1 mm, 2%/2 mm, and 3%/3 mm, respectively. Secondary validation yielded no significant differences in synCT performance for whole-brain MAE, PSNR, and SSIM with comparable dosimetric results. CONCLUSIONS: Our conditional generative adversarial network model generated high-fidelity brain synCTs from low-field MR imaging with excellent dosimetric performance. Secondary validation suggests great promise of implementing synCTs to facilitate robust dose calculation for online adaptive brain MR-guided radiation therapy.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Yan Y, Kim JP, Nejad-Davarani SP, et al. Deep Learning-Based Synthetic Computed Tomography for Low-Field Brain Magnetic Resonance-Guided Radiation Therapy. Int J Radiat Oncol Biol Phys. 2024. PMID: 39357787. doi:10.1016/j.ijrobp.2024.09.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。